Top Paying Companies
The manufacturers and group purchasing organizations (GPOs) that disclosed the largest general payments to covered U.S. healthcare providers in CMS Open Payments program year 2025. Figures are summed across the 16,096,287 provider-recipient general-payment records in that year.
| # | Company / GPO | Total to Providers | Payment records | Share of General-Payment Total |
|---|---|---|---|---|
| 1 | ABBVIE INC. | $197,742,831.41 | 1,680,137 | 6.8% |
| 2 | Stryker Corporation | $121,223,193.78 | 210,085 | 4.2% |
| 3 | Medtronic, Inc. | $107,563,821.76 | 345,537 | 3.7% |
| 4 | Arthrex, Inc. | $105,488,512.05 | 46,198 | 3.6% |
| 5 | Boston Scientific Corporation | $90,003,044.63 | 297,868 | 3.1% |
| 6 | Zimmer Biomet Holdings, Inc. | $78,630,580.22 | 38,116 | 2.7% |
| 7 | DePuy Synthes Products, Inc. | $61,501,808.72 | 1,891 | 2.1% |
| 8 | Novo Nordisk AS | $61,441,714.73 | 823 | 2.1% |
| 9 | INTUITIVE SURGICAL, INC. | $57,498,715.55 | 101,261 | 2.0% |
| 10 | AstraZeneca Pharmaceuticals LP | $52,168,838.14 | 554,261 | 1.8% |
| 11 | Smith+Nephew, Inc. | $49,505,707.69 | 72,626 | 1.7% |
| 12 | Lilly USA, LLC | $48,207,881.24 | 425,910 | 1.7% |
| 13 | GENZYME CORPORATION | $42,596,263.36 | 203,784 | 1.5% |
| 14 | Janssen Biotech, Inc. | $41,682,655.22 | 384,734 | 1.4% |
| 15 | Amgen Inc. | $39,150,972.15 | 504,090 | 1.4% |
| 16 | PFIZER INC. | $36,761,664.25 | 549,399 | 1.3% |
| 17 | Abbott Laboratories | $36,218,307.24 | 264,321 | 1.3% |
| 18 | Novo Nordisk Inc | $36,120,172.93 | 512,626 | 1.2% |
| 19 | Globus Medical, Inc. | $35,819,712.71 | 55,914 | 1.2% |
| 20 | E.R. Squibb & Sons, L.L.C. | $31,687,004.47 | 248,993 | 1.1% |
| 21 | Alphatec Spine, Inc | $28,358,604.57 | 6,111 | 1.0% |
| 22 | Regeneron Healthcare Solutions, Inc. | $28,333,803.87 | 186,489 | 1.0% |
| 23 | ENCORE MEDICAL, LP | $23,997,331.07 | 3,232 | 0.8% |
| 24 | HISTOSONICS, INC. | $23,867,362.68 | 1,433 | 0.8% |
| 25 | Align Technology, Inc. | $23,775,241.18 | 69,799 | 0.8% |
Shares divide each company's dollar total by the source general-payment dollar total, rounded to one decimal place.
Why does this matter?
Healthcare companies disclosed $2,895,070,353.31 in general payments to covered healthcare providers in 2025, across 1,831 distinct paying entities. General payments include speaking and consulting fees, food and beverage, travel, gifts, and royalties. These records cover healthcare providers, including non-physician recipients; they do not establish that every recipient is a prescriber.
The CMS Open Payments database exists precisely so patients, journalists, and researchers can see these relationships. Browse the official portal for the complete, authoritative record.